A Stanford-led phase 3 trial shows gene therapy skin grafts significantly heal chronic wounds in patients with severe epidermolysis bullosa, reducing pain and improving quality of life.
The role of vitamin D in pregnancy is an example of work by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, investigating human development.
Ewan Birney, Director of EMBL’s European Bioinformatics Institute (EMBL-EBI), reveals how genomics could improve healthcare and pave the way to precision medicine.
Gábor Balázsi, Ph.D. from the Louis and Beatrice Laufer Center for Physical and Quantitative Biology and the Department of Biomedical Engineering at Stony Brook University in the U.S., shares his perspective on the field of synthetic biology in terms of the past, present and future.
Data linkage and sharing for healthy longevity together present a global challenge, in the view of Prof Makoto Suematsu, Japan Agency for Medical Research and Development and Rihana Diabo at the World Economic Forum.
The UK government announced the launch of a huge genetics project, working with GlaxoSmithKline and AstraZeneca, to understand diseases like dementia and cancer.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group Genomic medicine approaches – two contrasting case studies to note including the overall perspective, as well as the challenges and concerns in the field.
The European Red Cell Society’s met the partners of the EU intellectual training network RELEVANCE at Mount of Truth in Ascona, Switzerland to discuss the latest progress.
The healthcare sector is constantly changing, and many practices have been modified to become more efficient: So how can technology help with advancing surgeries?
Here, Jaqueline Zhao and Tim Jackson discuss the new regulations coming into force for China in 2019, after the gene-editing scandal which created international headlines.
